Bank of America
HRMY icon

Bank of America’s Harmony Biosciences HRMY Stock Holding History

Bank of America’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94M Sell
140,717
-134,341
-49% -$4.41M ﹤0.01% 3639
2025
Q4 		$10.3M Buy
275,058
+84,642
+44% +$2.78M ﹤0.01% 2829
2025
Q3 		$5.25M Sell
190,416
-79,804
-30% -$2.75M ﹤0.01% 3959
2025
Q2 		$8.54M Buy
270,220
+898
+0.3% +$28.9K ﹤0.01% 3370
2025
Q1 		$8.94M Buy
269,322
+66,814
+33% +$2.4M ﹤0.01% 3246
2024
Q4 		$6.97M Sell
202,508
-113,458
-36% -$3.9M ﹤0.01% 3274
2024
Q3 		$12.6M Buy
315,966
+32,635
+12% +$1.15M ﹤0.01% 2853
2024
Q2 		$8.55M Buy
283,331
+209,525
+284% +$6.3M ﹤0.01% 3095
2024
Q1 		$2.48M Buy
73,806
+39,461
+115% +$1.27M ﹤0.01% 4283
2023
Q4 		$1.11M Sell
34,345
-21,259
-38% -$593K ﹤0.01% 4899
2023
Q3 		$1.82M Buy
55,604
+31,339
+129% +$1.09M ﹤0.01% 4340
2023
Q2 		$854K Sell
24,265
-24,949
-51% -$861K ﹤0.01% 4900
2023
Q1 		$1.61M Buy
49,214
+3,193
+7% +$145K ﹤0.01% 4536
2022
Q4 		$2.54M Buy
46,021
+1,013
+2% +$55.7K ﹤0.01% 4043
2022
Q3 		$1.99M Buy
45,008
+13,044
+41% +$636K ﹤0.01% 4280
2022
Q2 		$1.56M Buy
31,964
+4,344
+16% +$196K ﹤0.01% 4513
2022
Q1 		$1.34M Sell
27,620
-9,406
-25% -$384K ﹤0.01% 4962
2021
Q4 		$1.58M Buy
37,026
+21,461
+138% +$855K ﹤0.01% 4793
2021
Q3 		$597K Buy
15,565
+10,095
+185% +$325K ﹤0.01% 5505
2021
Q2 		$155K Sell
5,470
-4,327
-44% -$130K ﹤0.01% 6256
2021
Q1 		$324K Buy
9,797
+8,203
+515% +$288K ﹤0.01% 5701
2020
Q4 		$58K Buy
1,594
+1,562
+4,881% +$63K ﹤0.01% 6262
2020
Q3 		$1K Buy
+32
New +$1.17K ﹤0.01% 6768

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America's HRMY Position: Q1 2026 in Review

Bank of America reduced its Harmony Biosciences (HRMY) stake by 49% in Q1 2026, selling an estimated $4.41M and leaving 140,717 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3639.

Bank of America first reported a position in HRMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $12.6M in Q3 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Bank of America held 140,717 shares of Harmony Biosciences worth $3.94M as of Q1 2026.
  • Bank of America sold 134,341 Harmony Biosciences shares in Q1 2026, an estimated $4.41M.
  • Harmony Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3639 holding.
  • Bank of America first reported a position in Harmony Biosciences in Q3 2020 and has held it in 23 quarters since.
  • Bank of America's Harmony Biosciences position peaked at $12.6M in Q3 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.